SC 13G

Company

Hepion Pharmaceuticals, Inc.

Filed

August 17, 2016

Accession Number

0001104659-16-140283

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →